Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded, Endoscopic Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects

NCT01646814 is registered in ClinicalTrials.gov with PLx Pharma as lead sponsor.

NCT NCT01646814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01646814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded, Endoscopic Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects
Lead sponsor
PLx Pharma
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
June 30, 2013
Enrollment
247 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

gastroduodenal ulceration